popup

Sobi.IMMUNO-101 (anakinra), 0 NCT04324021

anakinra vs. standard of care

COVID 19 all comers

RECOVERY, 2022 NCT04381936

baricitinib vs. standard of care

COVID 19 all comers

Sobi.IMMUNO-101 (emapalumab), 0 NCT04324021

emapalumab vs. standard of care

COVID 19 all comers

ruxolitinib NOVARTIS, 0

ruxolitinib vs. control

COVID 19 all comers

TOCIVID (sarilumab), 0 NCT04322773

sarilumab vs. standard of care

COVID 19 all comers

sarilumab phase 2 high dose, 0 NCT04315298

sarilumab high dose (400mg) vs. placebo

COVID 19 all comers

sarimulab phase 2 low dose, 0 NCT04315298

sarilumab low dose (200mg) vs. placebo

COVID 19 all comers

First Affiliated Hospital of Wenzhou Medical University, 0 NCT04273581

thalidomide vs. placebo

COVID 19 all comers

ChiCTR2000030894 -TOCI, 0 ChiCTR2000030894

tocilizumab vs. favipiravir

COVID 19 all comers

NCT04356937, 0 NCT04356937

tocilizumab vs. placebo

COVID 19 all comers

BACC Bay Tocilizumab Trial, 2020 NCT04356937

tocilizumab vs. placebo

COVID 19 all comers

TOCIVID (tocilizumab), 0 NCT04322773

tocilizumab vs. standard of care

COVID 19 all comers

TOCOVID, 0 NCT04332094

tocilizumab vs. standard of care

COVID 19 all comers

NCT04330638, 0 NCT04330638

tocilizumab vs. standard of care

COVID 19 all comers